Proteomic profiling distinguishes astrocytomas and identifies differential tumor markers

Neurology
J LiRobert J Weil

Abstract

Methods to permit more precise delineation of astrocytomas of different grades may have therapeutic utility. The authors selectively microdissected pure populations of cells from normal brain and astrocytomas. They performed two-dimensional protein gel electrophoresis (2DGE) followed by protein sequencing. Differential expression was confirmed immunohistochemically. 2DGE identified proteomic patterns and proteins that differentiated normal brain from tumor and distinguished astrocytomas of increasing grade.

Citations

Jul 17, 2012·Journal of Proteome Research·Xueping FangCheng S Lee
Aug 20, 2011·Neuro-oncology·Juliya KalininaErwin G Van Meir
Dec 18, 2013·Neuro-oncology·Nina HeldringOla Hermanson
Dec 1, 2007·Expert Opinion on Medical Diagnostics·Fatima W Khwaja
Sep 1, 2009·Expert Opinion on Medical Diagnostics·Abderrahmane HamlatLaurent Riffaud
Mar 25, 2010·Journal of Proteomics·Simone P NiclouUros Rajcevic
Sep 26, 2008·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Jinyuan ZhouPeter C M van Zijl
Jan 28, 2015·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Kun YanJinyuan Zhou
Oct 21, 2018·Japanese Journal of Radiology·Kiyohisa KamimuraTakashi Yoshiura
Jan 20, 2010·Nature Reviews. Genetics·Valentina PerissiMichael G Rosenfeld
Sep 26, 2014·Neuro-oncology·Johan M KrosPing-Pin Zheng
Jul 18, 2017·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Shanshan JiangJinyuan Zhou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.